These novel therapies , Retatrutide, represent a remarkable advancement in addressing type 2 diabetes and conceivably associated disorders. These drugs are grouped as GLP-1 hormone activators , meaning they function to emulate the natural GLP-1 substance , enhancing glucose release and reducing h